Luxembourg is planning to purchase 30kg of medical cannabis after high demand left patients facing a shortage last year.
Health Minister Paulette Lenert announced in parliament in response to a question that the country planned to buy 30kg which would total approximately €3 million. She confirmed she had asked the finance ministry to increase the current allowance.
Lenert said that 28.5kg of cannabis with tetrahydrocannabinol (THC) levels of 18 percent and 2.25 kg with 10 percent THC have been ordered.
This is a higher amount than the €800,000 that was budgeted for 2021. However, by September 2020 there were already 441 patients prescribed in comparison to 415 for the entire previous year.
Cannabis was legalised for medical use in 2018 for cancer or multiple sclerosis but remains illegal for recreational use. The law will be evaluated at a later stage. COVID-19 delayed plans for Luxembourg to consider recreational use which is thought to be another two years away.
The first prescriptions for patients began in February 2019 and a six-month study has started in February 2021 which will advise the government on the success of the policy.
Luxembourg faced a shortage as demand unexpected surged. The minister also revealed that demand in 2020 was three times higher than in 2019. Doctors prescribed 140 kg of medical cannabis last year. It can only be accessed through hospital pharmacies in Luxembourg.
In just the first four months of 2021, doctors prescribed close to 70 kg of cannabis which was half the total of 2020. It was estimated that there were 630 patients as of June 2021 averaging 40 g of the plant each. Some patients were reportedly waiting for their prescription for over 60 days during the height of the delay.
In September of 2020, there were roughly 2,200 GPs in Luxembourg of which only 240 were authorised to prescribe cannabis. The doctors must undergo a six-hour training session before they are allowed to
There are roughly 2,200 GPs in Luxembourg, but only 240 of them are authorised to prescribe cannabis. “In order to issue a prescription, a doctor must first follow a training session. It’s a short one, I believe only six hours. 240 doctors have completed that, and they have given all prescriptions.”
Authorities were forced to find new suppliers. They are now being supplied by Tilray Deutschland who currently supplies to Germany, Portugal, Poland and Ireland. Its produce is sourced from Portugal and Canada. The maximum amount that the country can import is controlled by the International Narcotics Control Board and increased from 183 kg to 270 kg last year.
- The role of the endocannabinoid system in dermatological diseases
- Cannabis may help reduce reliance on other stimulants, finds study
- Greece welcomes ‘new era’ of medical cannabis after seven-year wait
- Spain publishes draft medical cannabis framework, but omits flower
- Broughton: How to design a robust CBD testing strategy
- Medical Cannabis Division of Rokshaw Ltd Rebranding to Curaleaf Laboratories
News5 months ago
FSA drops recommended daily dose of CBD to 10mg – everything you need to know
Pain6 months ago
Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study
News4 months ago
UK government accepts ACMD recommendations for CBD products
Industry5 months ago
First UK-grown cannabis medicine expected by end of 2023
News6 months ago
The Netherlands to launch cannabis legalisation pilot December 2023
News6 months ago
BBC documentary highlights ‘pot luck’ of access to cannabis on NHS
Science5 months ago
New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders
News4 months ago
Europe’s first legal cannabis dispensaries to open under sixth Swiss pilot